birinapant
Showing 1 - 9 of 9
Locally Recurrent Head and Neck Squamous Cell Carcinoma, Nasopharyngeal Squamous Cell Carcinoma, Sinonasal Squamous Cell
Recruiting
- Locally Recurrent Head and Neck Squamous Cell Carcinoma
- +2 more
- Birinapant
- Intensity-Modulated Radiation Therapy
-
Birmingham, Alabama
- +32 more
Aug 20, 2022
Acute Myelogenous Leukemia Trial in Philadelphia (Birinapant)
Terminated
- Acute Myelogenous Leukemia
- Birinapant
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 23, 2021
High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Primary Peritoneal High Grade Serous
Withdrawn
- High Grade Fallopian Tube Serous Adenocarcinoma
- +5 more
- Birinapant
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020
Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Worldwide (birinapant, Azacitidine, Placebo)
Terminated
- Myelodysplastic Syndrome (MDS)
- Chronic Myelomonocytic Leukemia (CMML)
- birinapant
- +2 more
-
Glendale, Arizona
- +75 more
Oct 18, 2016
Hepatitis B Trial in Adelaide, Melbourne, Nedlands (Antiviral Therapy (tenofovir or entecavir), Birinapant, Placebo (for
Terminated
- Hepatitis B
- Antiviral Therapy (tenofovir or entecavir)
- +2 more
-
Adelaide, South Australia, Australia
- +2 more
Feb 4, 2016
Relapsed Epithelial Ovarian Cancer, Relapsed Primary Peritoneal Cancer, Relapsed Fallopian Tube Cancer Trial in United States
Completed
- Relapsed Epithelial Ovarian Cancer
- +2 more
- Birinapant
- Conatumumab
-
Fresno, California
- +8 more
Jan 13, 2016